Introduction {#S1}
============

The ureteral ectopia occurs in approximately 1/2,000 newborn. The ectopic ureter is characterized by ending outside its normal opening in the trigone and always at one point along the embryonic mesonephric system path. 80% of patients is associated with a nephroureteral duplicated system, where the upper pole is often dysplastic or with minimal function ([@B1]--[@B4]). However, this ectopic ureteral ending is usually obstructive with the consequent risk of severe urinary tract infection (UTI) or loss of renal function if present.

Definitive surgery for symptomatic obstructive ectopic ureter in small infants is challenging ([@B5]--[@B7]). Traditional approach with ureteral reimplantation has shown complications due to the small size of the bladder and the large size of the dilated megaureter ([@B8], [@B9]). For this reason, temporary urinary diversions could be indicated during first months of life ([@B7], [@B10]), but are not exempt of complications. External ureterostomies may present problems such as infections, skin irritations, and stenosis. In addition, parental tolerance is usually low demanding early closure ([@B10]--[@B12]). Percutaneous nephrostomies could be done with external tubes but have limited durability in small infants.

Other procedures have been proposed to avoid bladder surgery in cases of huge obstructive ectopic ureters. Ipsilateral ureteroureterostomies ([@B13]) have been done with acceptable results even through minimally invasive techniques ([@B14]--[@B16]). In the same way, upper urinary tract approach (lumbar ureteroureterostomies or upper pole heminephrectomy if indicated) could be done laparoscopically, but all these procedures are technically demanding in small infants ([@B5], [@B17], [@B18]). Other authors advocate performing a refluxing megaureter reimplantation through a small laparotomy, as a temporary internal urinary diversion, with definitive ureteral reimplantation months later ([@B19]--[@B21]).

We propose to create an endoscopic urinary diversion (EUD) in the initial management of symptomatic ectopic obstructive ureter in infants. The aim of this novel surgical technique is to create a temporary internal urinary diversion to release obstruction, avoiding renal function impairment if present and severe UTIs until definitive surgery is done. We report our experience with this minimally invasive approach and analyze the results and outcomes in a group of patients.

Patients and Methods {#S2}
====================

A retrospective review of patients with ectopic obstructive ureter treated between 2006 and 2015 was conducted. Sixteen consecutive obstructive ectopic ureters (14 patients) were initially treated by EUD in this period. In other three patients, this approach was not feasible, in two girls with ectopic ureter ending in vagina and one boy in seminal vesicle. In those patients, ectopic ureter ran away from the bladder without protruding in it during cystoscopy, being the transvesical puncture unsuccessful. Then, video-assisted ureteroureterostomy was performed in those cases.

Twelve patients had prenatal diagnosis of hydronephrosis and received antibiotic prophylaxis since birth; the other two patients were diagnosed after febrile UTI. Twelve patients had unilateral ectopic ureter (eight left side/four right side) corresponding to the upper pole unit in duplicated reno-ureteral systems. The remaining two cases were bilateral ectopic ureters in non-duplicated kidneys.

The presumptive diagnosis of ectopic obstructive ureter was established in all cases attending to sonographic images, renal scintigraphy scans, and voiding cystography. In eight patients, URO-MR was necessary to achieve diagnosis.

US was used to measure the diameter of pelvis, calyces, distal ureter, and the characteristics of renal parenchyma. Hydroureteronephrosis grade was defined according to the guidelines of the Society of Fetal Urology. It was done at birth (in cases of prenatal diagnosis), at 1 month of life, and then every 3 months. Preoperative ultrasonography showed urinary tract dilatation worsening with grade IV hydronephrosis in all cases and bilateral grade III hydronephrosis in a girl without duplicity at time of treatment. None had VUR to the affected ureter.

Mercaptoacetyltriglycine (MAG-3) renal scans revealed obstructive pattern in all ectopic ureters, with severe loss of function of the upper pole moiety (UPM) in four patients (less than 15% of the split renal function), and mild-to-moderate hypofunction in four (less than 40% of the split renal function). The remaining renal unities (*n* = 8) preserved normal function.

Ectopic ureter was always confirmed by cystoscopy. It was indicated in those patients with high suspicion at the imaging tests, with urinary tract dilatation worsening at the US scans and breaking through UTIs despite antibiotic prophylaxis. Renal function or split function of the affected upper pole did not influence in the surgical indication since only symptomatic patients with at least two febrile UTI or urinary sepsis were treated. Furthermore, two patients with severe loss of function of the UPM were treated during urinary sepsis with uretero-pyonephrosis.

When ectopic meatus was not found or was localized in the vagina or in urethrovaginal wall, EUD of the ectopic megaureter consisted in the creation of a transurethral neo-orifice (TUNO) performed by puncturing of the vesicoureteral wall, under fluoroscopic and ultrasound control.

If the obstructive ectopic meatus was identified in the posterior urethra, "intravesicalization procedure" was done, by opening the urethral--ureteral wall with electrocautery to create a ureteral outlet into the bladder.

Clinical data, ultrasonography images, scintigraphy scans, and outcome were preoperatively and postoperatively analyzed. Statistical analysis was performed with IBM SPSS statistics 20.0, using Chi-square test for qualitative variables, and Student's *t*-test and Wilcoxon test for quantitative analyses.

Surgical Technique {#S2-1}
------------------

### Creation of a TUNO {#S2-1-1}

Under general anesthesia and with antibiotic prophylaxis, a cystoscopy (with a 9.5-Fr Storz cystoscope with 5-Fr working channel) is done.

When ectopic meatus is not found, bladder is punctured where the ectopic ureter protrudes with a 3-Fr needle under direct cystoscopic vision and ultrasound guidance, performing an orifice distal to the trigone. In females, we try to locate the ectopic meatus in the vagina or in the urethrovaginal wall, and in case of finding, high-pressure retrograde pyelography is done to facilitate the posterior vesicoureteral puncturing.

If urine output is observed, radiological contrast is introduced through the needle performing retrograde pyelography under fluoroscopic vision. Then, a hydrophilic flexible guidewire (0.014″ or 0.018″ Terumo^®^) is passed through the ectopic ureter followed by a 5-mm high-pressure balloon (RX Muso, Terumo™), which is inflated to its nominal pressure (14 atm) creating the neomeatus. Neomeatus edges are coagulated with monopolar electrocautery to prevent early closure, and finally a double J ureteral stent (3-Fr, 8--12 cm long, Sof-Flex Multi-Length Ureteral Stent Cook Urological Incorporated™) is left in place for 3--4 weeks (Figures [1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}).

!["TUNO" under radioscopic control and postoperative control 3 months later. **(A)** Puncturing of ectopic ureter. **(B)** Retrograde uretero-pyelography. **(C)** Balloon dilatation of the puncturing point creating the neomeatus. **(D)** Neomeatus 3 months later. TUNO, trans-urethral neo-orifice.](fped-05-00208-g001){#F1}

![Creating "TUNO" under US and radioscopic control. **(A)** Cystoscopic view of posterior urethra, where ectopic ureter bulges. **(B)** Puncturing vesicoureteral wall under US control (note echogenic guide wire inside the ureter). **(C,D)** Retrograde uretero-pyelography. **(E)** Final appearance of neomeatus with double J stent. TUNO, trans-urethral neo-orifice.](fped-05-00208-g002){#F2}

### "Intravesicalization" Procedure {#S2-1-2}

When ectopic meatus is located at the posterior urethra, a 4-Fr ureteral catheter is inserted to perform a retrograde pyelography. After pyelography, urethral--ureteral wall is opened with monopolar electrocautery to create a ureteral opening into the bladder. The new ureteral outlet should be on the bladder neck or above to ensure continence, but away from the trigone to avoid injuring the lower pole ureter. We try to perform a limited opening, preserving a bladder mucosal flap above that could partially cover it during bladder filling phase (Figure [3](#F3){ref-type="fig"}).

!["Intravesicalization procedure" of bilateral ectopic ureters in a girl with anorectal malformation. **(A)** Right ectopic ureteral meatus. **(B)** Ureteroscopy of right ureter. **(C)** Left ectopic ureteral meatus. **(D)** Ureteroscopy of left ureter. **(E)** Both ectopic meatus localized at urethra. **(F,G)** "Intravesicalization" of right meatus. **(H,I)** "Intravesicalization" of left meatus. **(J)** Final result.](fped-05-00208-g003){#F3}

Follow-up {#S2-2}
---------

Patients maintained antibiotic prophylaxis and were controlled clinically and with US scan 1 month after EUD and then every 3 months. MAG-3 renal scans and VCUG were performed at the sixth postoperative month.

At 1 year of age, treatment strategy was individualized according to the parents. If UTI occurred during follow-up, definitive surgery was proposed: --In patients with secondary VUR and renal function preserved, single endoscopic treatment of reflux with subureteral Macroplastique^®^ (*polydimethylsiloxane*) injection or ureteral reimplantation was offered.--In cases of non-functioning upper pole, heminephrectomy was indicated.

On the other hand, patients who remained asymptomatic were long-term evaluated clinically and with US scans every 6 months. In those cases of asymptomatic secondary VUR, single attempt of endoscopic anti-reflux treatment was offered, with expectant follow-up not performing VCUG routinely (Table [1](#T1){ref-type="table"}).

###### 

Flow chart after endoscopic urinary diversion (EUD) in obstructive ectopic megaureter.

  -----------------------------
  ![](fped-05-00208-i001.jpg)
  -----------------------------

Results {#S3}
=======

A total of 16 ectopic ureters in 14 patients were treated from 2006 to 2015, with a median follow-up of 48 months (24--136).

Endoscopic urinary diversion was performed at a median age of 3.5 months (0.5--7), with a median operative time of 35 min (15--70). TUNO was performed in six patients and "intravesicalization" in eight patients. The length of hospital stay was 24 h in all patients, except in two in whom the endoscopic approach was done during hospital admission for urinary sepsis and uretero-pyonephrosis, requiring medical assistance after the procedure during 3 and 9 days, respectively. In one infant, the "intravesicalization" procedure was performed on an outpatient basis. No intraoperative complications were observed.

Attending to the US findings, important improvement was observed in uretero-hydronephrosis, with statistically significant differences in ureteral diameter and anterioposterior pelvis diameter before and after endoscopic treatment (*p* \< 0.005) (Table [2](#T2){ref-type="table"}). Postoperative MAG-3 renal scan revealed resolution of the obstruction in all cases, preserving initial renal or split renal function.

###### 

Renal US findings in patients with endoscopic urinary diversion.

                                               Preoperatory    Late p.o. US   *p* Value (Wilcoxon test)
  -------------------------------------------- --------------- -------------- ---------------------------
  Median distal ureter diameter, mm (range)    17 (30--10)     9 (14--5)      \<0.005
  Median anterioposterior pelvis, mm (range)   16.5 (27--11)   7 (17--4)      \<0.005

Postoperative complications were UTI in four patients and early TUNO stenosis in one who required endoscopic balloon dilatation. It was suspected after an early UTI presented 3 weeks later, with uretero-hydronephrosis worsening. Cystoscopy showed severe neo-orifice stenosis, requiring balloon dilatation with a 6-mm high-pressure balloon, being the patient free of symptoms since then.

Secondary VUR was confirmed in 11/16 cases, but was asymptomatic in most of them. A single STING procedure was offered in all patients with secondary VUR, being done in nine cases, eight of them with non-symptomatic reflux. Subsequent follow-up was done with periodical clinical evaluation and US scans every 6 months, performing VCUG only in cases of persistent urinary tract dilation or symptoms.

Finally, four patients underwent definitive treatment that consisted in three heminephrectomies and one ureteral reimplantation. Heminephrectomies were done in those cases of non-functioning UPM and symptomatic UTI after EUD (two in TUNO group and one in "intravesicalization" group). Ureteral reimplantation was performed in one case of persistent secondary VUR; this reflux was low grade and symptom-free but parents preferred definitive surgery repair.

The remaining patients (10/14) maintained asymptomatic during follow-up with progressive improvement of the urinary tract dilatation in the US, so no further treatments were needed. Continence was evaluated in all of them during long-term, and all patients over 3 years old referred to be dry (actually only one patient is 2-year olds and is now acquiring continence).

Results, complications, and treatments are summarized in Table [3](#T3){ref-type="table"}.

###### 

Clinical data, complications, and treatments in patients with endoscopic urinary diversion.

  Age                                          Hydronephrosis grade pre/post   APD pre/post (mm)   RUD pre/post (mm)   Renal scintigraphy (UPM)   Postoperative urinary tract infection (UTI)   2° VUR   Reoperation            Definitive treatment
  -------------------------------------------- ------------------------------- ------------------- ------------------- -------------------------- --------------------------------------------- -------- ---------------------- -------------------------
  **Transurethral neo-orifice (TUNO) group**                                                                                                                                                                                    
                                                                                                                                                                                                                                
  3 months                                     IV/II                           23/8                27/4                Severe loss of function    1                                             No       No                     Heminephrectomy
  2 months                                     IV/III                          20/10               21/9                Severe loss of function    0                                             Yes      STING                  No
  16 days                                      IV/IV                           18/14               15/15               Severe loss of function    1                                             Yes      No                     Heminephrectomy
  2 months                                     II/II                           8/9                 20/17               Hypofunction               1 early                                       No       "TUNO" re-dilatation   No
  5 months                                     IV/II                           17/10               17/9                Normal                     2                                             Yes      STING + Circumcision   No
  5 months                                     IV/I                            16/7                20/7                Normal                     0                                             Yes      STING                  No
                                                                                                                                                                                                                                
  **"Intravesicalization" group**                                                                                                                                                                                               
                                                                                                                                                                                                                                
  6 months                                     IV/II                           24/14               18/8                Normal                     0                                             Yes      STING                  Ureteral reimplantation
  6 months                                     IV/II                           25/12               16/4                Hypofunction               0                                             Yes      STING                  No
  4 months                                     IV/II                           26/14               21/9                Severe loss of function    2                                             Yes      No                     Heminephrectomy
  7 months                                     IV/I                            16/7                14/7                Hypofunction               0                                             Yes      STING                  No
  2 months[^a^](#tfn1){ref-type="table-fn"}    Right III/I                     12/7                13/6                Normal                     0                                             No       No                     No
  Left III/I                                   13/8                            12/5                Normal                                                                                                                       
  5 months                                     IV/I                            14/8                13/8                Normal                     0                                             No       No                     No
  2 months                                     IV/III                          30/13               17/7                Hypofunction               0                                             Yes      STING                  No
  3 months[^a^](#tfn1){ref-type="table-fn"}    Right IV/II                     14/5                11/4                Normal                     0                                             Yes      STING                  No
  Left IV/II                                   15/7                            12/4                Normal              Yes                        STING                                         No                              

*APD, anterioposterior pelvic diameter; RUD, retrovesical ureteral diameter; UPM, upper pole moiety*.

*^a^Patient with bilateral ectopic ureters in non-duplicated kidneys*.

Discussion {#S4}
==========

Neonates and infants with distal ureteral obstruction are at risk of severe UTI and renal loss function. There is still controversy about the need for a temporary urinary diversion or the possibility of complete surgical correction in early stages of life, with special consideration in the small size of the bladder and its disproportion with the diameter of the obstructed ureter. It is known that there is a significant risk of postoperative complications in these patients ([@B22]), so alternate techniques have been proposed.

The objective of the initial treatment in obstructive ectopic ureter with recurrent UTI in infants would be to achieve good urine drainage of the obstructive ureter, thereby decreasing the risk of UTI and preserving renal function if present. Accordingly, temporary urinary diversion has proven to be helpful in achieving these objectives ([@B10]). Our goal should be to minimize the morbidity associated with these procedures while reaching the same objectives.

Percutaneous nephrostomies could achieve an immediate hydronephrosis improvement, even though their durability is limited in early infants due to drains twists or removal. Therefore, its usefulness is limited to short periods of time ([@B13]). Furthermore, its placement in infants is not easy, being described up to 8% of complications including bleeding requiring transfusion, sepsis, or accidental puncture of the pleura or peritoneum ([@B23]).

Cutaneous ureterostomies are especially useful when the goal is to maintain the effect of the urinary diversion for several weeks or months ([@B10]). Therefore, it may be considered as the first-line treatment in those infants with a large ureteral dilatation that could interfere with a feasible and safe ureteral reimplantation ([@B20]). However, several complications have been described in over 25% of cases, as peristomal skin irritation, infection, or stomal stenosis ([@B11]). In some occasions, they are poorly tolerated by parents who do not take care of them adequately ([@B10]--[@B12]).

To avoid this morbidity, internal urinary diversions have become popular, as proposed by Kaefer et al. ([@B19]--[@B21]), who perform a refluxing megaureter reimplantation through a small laparotomy during the first months of life until definitive surgery is feasible.

The creation of a "TUNO" or the intravesicalization of ectopic meatus pretends to be a endoscopic mean of relieving severe obstruction, to avoid recurrent UTIs and renal function impairment if present, until a future definitive surgery repair is done ([@B24], [@B25]). Only symptomatic patients with uncontrolled UTIs or in the situation of urinary sepsis were treated. For these reasons, function of the affected upper moiety did not influence in the surgical indication. In our series, four patients were initially treated with a very low split renal function (\<15%) of the upper pole affected. In two of them (one baby was 16 day olds), endoscopic approach was performed during hospital admission for urinary sepsis and uretero-pyonephrosis. Renal function did not improve in any of them and finally heminephrectomy was performed in three patients 6--12 months later. However, the internal drainage allowed the child to mature and definitive heminephrectomies were done in safe and better conditions. One patient maintained asymptomatic after endoscopic diversion, so an expectant attitude was decided.

We propose this novel technique that is really minimally invasive, with a short operative time and hospital stay and with minimal postoperative disturbance. Furthermore, the ureteral rest left in the creation of a neomeatus is minimal compared to other techniques ([@B6], [@B19]), probably diminishing risks of future complications.

It is important to have on mind that "intravesicalization" procedure is technically easier than the creation of a TUNO, which requires a higher learning curve in endourology. The visualization of the ectopic meatus and the ureteral tract facilitates its endoscopic approach. However, in the creation of a TUNO, we must intuit the ureter path and the adequate puncture site trough the ureterovesical wall. In this way, it is easy to imagine that the complication rate should be higher for the neomeatus procedure than for the "intravesicalization." However, the most common complication is not finding the ectopic ureter, probably because the ureterovesical wall is thicker than imagined. In our series, no bladder injuries and no perforations of other viscera occurred. The puncture needle has a very low profile and limited length to avoid these possible complications. Those endoscopic approaches have proven to be safe procedures, with fewer complications than other techniques like the refluxing megaureter reimplantation ([@B21]) or the laparoscopic/video-assisted ureteroureterostomy ([@B14]).

The most frequent complication observed was secondary reflux. Although it is not a desirable condition, it is easier to manage than obstruction and carries less risk for continued renal injury. However, it was asymptomatic in most cases and did not result in significant morbidity for the patients.

It should be emphasized that this endoscopic procedure aims to be a temporary and minimally invasive internal urinary diversion, preserving renal function if present until a time at which these patients could undergo a definitive repair. However, several patients stayed asymptomatic and with resolution of the urinary tract dilatation during postoperative follow-up and therefore, an expectant behavior was kept as in current treatment protocols for ureterocele ([@B5]).

The present communication has obvious limitations considering it is a descriptive retrospective study with no control group and so our results should be compared with the literature.

Conclusion {#S5}
==========

This EUD has shown to be a feasible technique in the initial management of symptomatic obstructive ectopic ureter. It is a really minimal invasive procedure for a challenging pathology that presents in small infants, allowing an adequate ureteral drainage in cases of severe obstruction with high risk of uncontrollable UTI or uretero-pyonephrosis. The objective of this technique is to be a temporary internal drainage to control urinary infections, preserve initial renal function, and facilitate the baby to mature until definitive surgery is proposed months later. It is reproducible, safe, and does not invalidate other surgical options in case of failure or future definitive treatments.
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